Zentiva Romania reports solid financial results for 2025
Zentiva Romania, one of the most important pharmaceutical manufacturers on the local market, has announced the financial results recorded at the end of 2025. Official data show a positive business evolution, consolidating the company's position in the national pharmaceutical industry.
According to the financial report, Zentiva Romania ended last year with a turnover of approximately 1.7 billion lei. This performance reflects intense activity in the pharmaceutical market, supported by constant demand for pharmaceutical products manufactured in local facilities.
In addition to the generated revenue, the company reported a profit of 276 million lei. Furthermore, Zentiva remains a major employer in the industrial sector, currently having a team of nearly 1,500 employees working in the company's two production units.
These results will be discussed during the "ZF Health & Pharma" event, which will take place from September 28-29. Simona Cocoș, the manufacturer's general manager, will also attend this conference to provide details on the company's development strategy for the coming period.
Zentiva's financial success underscores the importance of local medicine production for Romania's economy. By maintaining a high number of jobs and a steady turnover, the company continues to be a central pillar in the healthcare system and the Romanian business environment.